ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000061 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
2,468
Total Value
$797,350.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 114 | $319.03 | $36,369.42 | 64,159 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 109 | $320.01 | $34,881.09 | 64,050 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 230 | $320.81 | $73,786.30 | 63,820 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 309 | $321.82 | $99,442.38 | 63,511 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 374 | $323.01 | $120,805.74 | 63,137 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 818 | $323.84 | $264,901.12 | 62,319 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 291 | $324.88 | $94,540.08 | 62,028 | Direct | โ | View Details | |
EVP, Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 223 | $325.67 | $72,624.41 | 61,805 | Direct | โ | View Details |